Faeth Therapeutics, Inc.

NASDAQ:FTH

Biotechnology

Healthcare
$8.72 +5.01%

+$1.43 today

Market cap
$224.79M
Beta
-0.31
P/E (TTM)
-0.2
EPS (TTM)
-$34.65
52W Low $7.21High $37.90

Volume 0.33M

Average 0.12M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$22.29M

FY 2025 · Annual

Net Income

-$21.09M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue685K1.81M571K551K0
Gross Profit(685K)(1.81M)(571K)(551K)0
Gross Margin—————
Research & Development21.66M29.58M18.3M18.63M10.96M
Selling, General & Admin15.14M17.73M18.77M12.49M11.33M
Operating Expenses36.8M47.31M36.49M31.11M22.29M
Depreciation & Amortization685K1.81M3.68M551K139K
EBITDA(35.44M)(46.56M)(33.39M)(29.52M)(20.91M)
EBITDA Margin—————
Operating Income(37.48M)(49.12M)(37.06M)(31.66M)(22.29M)
Operating Margin—————
Interest Income800K1.78M3.62M2.55M1.24M
Interest Expense670K219K144K90K32K
Other Income / Expenses688K532K2.96M1.51M1.2M
Income Before Tax(36.79M)(48.59M)(34.1M)(30.16M)(21.09M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(36.79M)(48.59M)(34.1M)(30.16M)(21.09M)
Net Margin—————
EPS (Basic)(26.56)(31.65)(24.40)(24.01)(16.72)
EPS (Diluted)(26.56)(31.65)(24.40)(24.01)(16.72)
Weighted Avg Shares1.39M1.54M1.4M1.26M1.26M
Weighted Avg Shares (Diluted)1.39M1.54M1.4M1.26M1.26M

FTH Earnings Waterfall · TTM

NASDAQ:FTH · Revenue to Net Income

Key Ratios

EPS$-141.65
Gross Margin0.0%
Net Margin23.5%
P/E Ratio-0.9
P/S Ratio-0.6

Analysis

-$4.9M of revenue converted into -$195.5M of net income for the selected period. Gross margin is 0.0% and net margin is 23.5%, showing how much revenue survives after costs and taxes. EPS is $-141.65, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 3, 2026
S-8S-8 filingNov 3, 2026

How much revenue does FTH generate?

Faeth Therapeutics, Inc. (FTH) reported $0.00 of revenue in fiscal 2025.

Is FTH profitable?

Faeth Therapeutics, Inc. (FTH) reported -$21.09M of net income.